Tag Archives: Trump Administration

Reform 340B Drug Pricing NOW

The 340B program continues to grow outside of its original purpose of helping the poor and uninsured — this is true, despite the promise that ObamaCare would vastly reduce the numbers of uninsured (and underinsured). Reforming the program will be a major defeat for Washington’s political class. Crony corporatists and their lobbyists have abused 340B to make themselves wealthier. Wealth creation is good, but not when a privileged few leverage government at the expense of patients and taxpayers.

We hear a lot about “draining the swamp,” but we don’t see a lot of action. With 340B reform, our elected officials have an opportunity to put patients over profits. Let’s hope they have the courage to do what’s right and necessary.

Read more about how the Trump Administration wants to reform 340B here: The Trump Administration is Right to Reform 340B.

CapAllies joins IPR Coalition Letter

COALITION: THE SEOUL HIGH COURT’S IMPENDING RULING ON EXTRATERRITORIALITY IN THE QUALCOMM MATTER WEAKENS TO INTELLECTUAL PROPERTY RIGHTS

 Washington D.C. – Today, a broad coalition of free-market and center-right organizations released a statement regarding a pending decision of Korea’s Seoul High Court, Korea’s court of last resort. The decision will be whether to stay the Korea Fair Trade Commission’s (KFTC’s) overbroad ruling against Qualcomm, Inc., the aggrieved party in the proceeding.

Below is the statement released by the coalition:

“We are troubled by the prospect that the Seoul High Court might fail to stay the KFTC’s grossly overbroad extraterritorial remedies against Qualcomm. Such a ruling by the Court would explicitly condone the KFTC’s intrusion upon U.S. sovereignty, resulting in far-reaching implications harmful to free trade, the United States economy, and intellectual property as a whole.

Earlier this year, the KFTC took the extraordinary step of seeking to impose a one-size-fits-all approach to how patents around the world are licensed. This unprecedented remedy is a bald-faced attempt to slash the value of a U.S. company’s global patent portfolio and shield Korean domestic companies from American competition.

“The KFTC’s extraterritorial remedies go well beyond protecting Korean consumers and purport to dictate the terms upon which a U.S. company can license its intellectual property—even well outside Korea’s borders.  Such remedies result in a major transfer of patented technology from U.S. to Korean companies, severely undermining U.S. leadership in innovation and economic growth. This will adversely impact every company in the United States that holds a patent of any kind.

“As the U.S. embarks upon a review of its trade and investment relationship with Korea, we urge the Trump Administration to demand assurances from the highest levels of the Korean government that all U.S. companies will be protected from the KFTC’s extraterritorial overreach. Anything less is a direct attack on our economy, our intellectual property, and our sovereignty.”  (PDF here: SKorea KFTC Case Ltr Aug2017)

Sincerely,

American Conservative Union

American Conservative Union Foundation

American Commitment

American Legislative Exchange Council

ALEC Action

American Business Defense Council

Americans for Limited Government

Capitol Allies

Conservatives for Property Rights

Consumer Action for a Strong Economy

Council for Citizens Against Government Waste

Eagle Forum Education & Legal Defense Fund

FreedomWorks

Frontiers of Freedom

Institute for Liberty

Less Government

Let Freedom Ring

Taxpayers Protection Alliance

Tea Party Patriots

Tradition, Family, Property, Inc.

U.S. Business & Industry Council